Chronic kidney disease (CKD) remains a critical public health issue globally, leading to end-stage renal disease (ESRD) that often requires renal replacement therapy, primarily through hemodialysis. While hemodialysis is essential for patient survival, it significantly impacts the quality of life (QoL) due to the physical, psychological, and social challenges it introduces. This study aims to assess the quality of life in hemodialysis patients, correlating these findings with various clinical outcomes to provide a comprehensive understanding of patient well-being and treatment efficacy.

Hemodialysis patients experience numerous adversities, including fatigue, dietary restrictions, fluid management issues, frequent hospital visits, and a general decrease in physical and mental health. These challenges contribute to a diminished QoL, necessitating a thorough evaluation to identify areas for improvement. This study aims to measure the QoL in hemodialysis patients using standardized tools and analyze the relationship between QoL scores and clinical outcomes such as laboratory results, hospitalization rates, and mortality. The ultimate goal is to identify key factors influencing QoL and develop targeted interventions to enhance patient care and outcomes.

Hemodialysis is a life-sustaining treatment for patients with end-stage renal disease. While it prolongs life, it also significantly impacts patients’ quality of life (QoL) and clinical outcomes. This study aims to comprehensively assess the QoL and clinical outcomes of hemodialysis patients. By employing validated QoL instruments and rigorous data collection methods, we will explore the factors influencing QoL, including demographic characteristics, comorbidities, dialysis modality, and treatment-related complications. Additionally, we will examine the relationship between QoL and clinical outcomes such as mortality, hospitalization rates, and cardiovascular events. This research will provide valuable insights into the lived experiences of hemodialysis patients, identify factors associated with poor QoL, and inform the development of targeted interventions to improve patient outcomes and overall well-being.

Hemodialysis, quality of life, clinical outcomes

Mushi L, Marschall P, Fleßa S. The cost of dialysis in low and middle-income countries: a systematic review. BMC Health Services Research.

Collins AJ, Foley RN, Chavers B, Gilbertson D, Herzog C, Ishani A, Johansen K, Kasiske BL, Kutner N, Liu J et al. US Renal Data System 2013 Annual Data Report. Am J Kidney Dis.

Foley RN, Collins AJ. The USRDS: what you need to know about what it can and can’t tell us about ESRD. Clinical Journal of the American Society of Nephrology.

Smith KW, Avis NE, Assmann SF. Distinguishing between quality of life and health status in

quality of life research: a meta-analysis. Quality of Life Research.

Evans RW, Manninen DL, Garrison Jr LP, Hart LG, Blagg CR, Gutman RA, Hull AR, Lowrie EG. The quality of life of patients with end-stage renal disease. New England Journal of Medicine.

Lowrie EG. Acute-phase inflammatory process contributes to malnutrition, anemia, and possibly other abnormalities in dialysis patients. American Journal of Kidney Diseases.

Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH. Association among SF36 quality of life measures and nutrition, hospitalization, and mortality in hemodialysis. Journal of the American Society of Nephrology.

World Health Organization: Preamble to the Constitution of the World Health Organization as adopted by the International Health Conference.

Barcaccia B. Quality Of Life: Everyone Wants It, But What Is It?. Forbes/Education. Retrieved.

Ferrans CE. Definitions and conceptual models of quality of life. Outcomes assessment in cancer: Measures, methods, and applications.

Garratt AM, Ruta DA, Abdalla MI, Buckingham JK, Russell IT. The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS?. Bmj.